The extracellular membrane-proximal domain of human membrane IgE controls apoptotic signaling of the B cell receptor in the mature B cell line A20

Journal of Immunology

Volumn 177, Issue 6, 2006, Pages 3597-3605

  Poggianella, Monica ^a   Bestagno, Marco ^a   Burrone, Oscar R ^a  

^a INTERNATIONAL CENTRE FOR GENETIC ENGINEERING AND BIOTECHNOLOGY   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

B LYMPHOCYTE RECEPTOR; CD40 ANTIGEN; IMMUNOGLOBULIN E; MITOGEN ACTIVATED PROTEIN KINASE 1; MITOGEN ACTIVATED PROTEIN KINASE 3;

ANIMAL CELL; APOPTOSIS; ARTICLE; B LYMPHOCYTE; CALCIUM MOBILIZATION; CELL LINE; CELL SURVIVAL; CONTROLLED STUDY; ENZYME PHOSPHORYLATION; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN DOMAIN; SIGNAL PROCESSING;

EID: 33748482189     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: 10.4049/jimmunol.177.6.3597     Document Type: Article

References (47)

1. Schamel, W. W., and M. Reth. 2000. Monomeric and oligomeric complexes of the B cell antigen receptor. Immunity 13: 5-14.
2. Shaw, A. C., R. N. Mitchell, Y. K. Weaver, J. Campos-Torres, A. K. Abbas, and P. Leder. 1990. Mutations of immunoglobulin transmembrane and cytoplasmic domains: effects on intracellular signaling and antigen presentation. Cell 63: 381-392.
3. Grupp, S. A., K. Campbell, R. N. Mitchell, J. C. Cambier, and A. K. Abbas. 1993. Signaling-defective mutants of the B lymphocyte antigen receptor fail to associate with Ig-α and Ig-βγ. J. Biol. Chem. 268: 25776-25779.
4. Geisberger, R., R. Crameri, and G. Achatz. 2003. Models of signal transduction through the B-cell antigen receptor. Immunology 110: 401-410.
5. Wakabayashi, C., T. Adachi, J. Wienands, and T. Tsubata. 2002. A distinct signaling pathway used by the IgG-containing B cell antigen receptor. Science 298: 2392-2395.
6. Achatz, G., L. Nitschke, and M. C. Lamers. 1997. Effect of transmembrane and cytoplasmic domains of IgE on the IgE response. Science 276: 409-411.
7. Kaisho, T., F. Schwenk, and K. Rajewsky. 1997. The roles of γ1 heavy chain membrane expression and cytoplasmic tail in IgG1 responses. Science 276: 412-415.
8. Weiser, P., R. Muller, U. Braun, and M. Reth. 1997. Endosomal targeting by the cytoplasmic tail of membrane immunoglobulin. Science 276: 407-409.
9. Bestagno, M., L. Vangelista, P. A. Mandiola, S. Mukherjee, J. Sepulveda, and O. R. Burrone. 2001. Membrane immunoglobulins are stabilized by interchain disulfide bonds occurring within the extracellular membrane-proximal domain. Biochemistry 40: 10686-10692.
10. Batista, F. D., D. G. Efremov, T. Tkach, and O. R. Burrone. 1995. Characterization of the human immunoglobulin ε mRNAs and their polyadenylation sites. Nucleic Acids Res. 23: 4805-4811.
11. Batista, F. D., D. G. Efremov, and O. R. Burrone. 1995. Characterization and expression of alternatively spliced IgE heavy chain transcripts produced by peripheral blood lymphocytes. J. Immunol. 154: 209-218.
12. Batista, F. D., S. Anand, G. Presani, D. G. Efremov, and O. R. Burrone. 1996. The two membrane isoforms of human IgE assemble into functionally distinct B cell antigen receptors. J. Exp. Med. 184: 2197-2205.
13. Pogue, S. L., and C. C. Goodnow. 1994. Ig heavy chain extracellular spacer confers unique glycosylation of the Mb-1 component of the B cell antigen receptor complex. J. Immunol. 152: 3925-3934.
14. Tisch, R., C. M. Roifman, and N. Hozumi. 1988. Functional differences between immunoglobulins M and D expressed on the surface of an immature B-cell line. Proc. Natl. Acad. Sci. USA 85: 6914-6918.
15. Guzman-Rojas, L., J. C. Sims-Mourtada, R. Rangel, and H. Martinez-Valdez. 2002. Life and death within germinal centres: a double-edged sword. Immunology 107: 167-175.
16. Chang, T. W. 2000. The pharmacological basis of anti-IgE therapy. Nat. Biotechnol. 18: 157-162.
17. Coyne, K. E., A. Crisci, and D. M. Lublin. 1993. Construction of synthetic signals for glycosyl-phosphatidylinositol anchor attachment: analysis of amino acid sequence requirements for anchoring. J. Biol. Chem. 268: 6689-6693.
18. Benvenuti, F., O. R. Burrone, and D. G. Efremov. 2000. Anti-idiotypic DNA vaccines for lymphoma immunotherapy require the presence of both variable region genes for tumor protection. Gene Ther. 7: 605-611.
19. Borsi, L., E. Balza, M. Bestagno, P. Castellani, B. Carnemolla, A. Biro, A. Leprini, J. Sepulveda, O. Burrone, D. Neri, and L. Zardi. 2002. Selective targeting of tumoral vasculature: comparison of different formats of an antibody (L19) to the ED-B domain of fibronectin. Int. J. Cancer 102: 75-85.
20. H determinants. Gene Ther. 8: 1555-1561.
21. Cesco-Gaspere, M., F. Benvenuti, and O. R. Burrone. 2005. BCL1 lymphoma protection induced by idiotype DNA vaccination is entirely dependent on antiidiotypic antibodies. Cancer Immunol. Immunother. 54: 351-358.
22. Jones, B., J. P. Tite, and C. A. Janeway, Jr. 1986. Different phenotypic variants of the mouse B cell tumor A20/2J are selected by antigen- and mitogen-triggered cytotoxicity of L3T4-positive, I-A-restricted T cell clones. J. Immunol. 136: 348-356.
23. Vuica, M., S. Desiderio, and J. P. Schneck. 1997. Differential effects of B cell receptor and B cell receptor-FcγRIIB1 engagement on docking of Csk to GTPase-activating protein (GAP)-associated p62. J. Exp. Med. 186: 259-267.
24. 2-terminal kinase, activation correlates with surface IgM-mediated apoptosis in the WEHI 231 B cell line. J. Immunol. 161: 1637-1644.
25. Sutherland, C. L., A. W. Heath, S. L. Pelech, P. R. Young, and M. R. Gold. 1996. Differential activation of the ERK, JNK, and p38 mitogen-activated protein kinases by CD40 and the B cell antigen receptor. J. Immunol. 157: 3381-3390.
26. Gauld, S. B., D. Blair, C. A. Moss, S. D. Reid, and M. M. Harnett. 2002. Differential roles for extracellularly regulated kinase-mitogen-activated protein kinase in B cell antigen receptor-induced apoptosis and CD40-mediated rescue of WEHI-231 immature B cells. J. Immunol. 168: 3855-3864.
27. 2 activation and resultant disruption of mitochondrial membrane potential correlate with the induction of apoptosis in WEHI-231 B cells. J. Immunol. 166: 137-147.
28. Gold, M. R. 2002. To make antibodies or not: signaling by the B-cell antigen receptor. Trends Pharmacol. Sci. 23: 316-324.
29. Niiro, H., and E. A. Clark. 2002. Regulation of B-cell fate by antigen-receptor signals. Nat. Rev. Immunol. 2: 945-956.
30. Eldering, E., and R. A. VanLier. 2005. B-cell antigen receptor-induced apoptosis: looking for clues. Immunol. Lett. 96: 187-194.
31. Silver, K., and R. J. Cornall. 2003. Isotype control of B cell signaling. Sci. STKE 2003: pe21.
32. Geisberger, R., M. Prlic, G. Achatz-Straussberger, I. Oberndorfer, E. Luger, M. Lamers, R. Crameri, U. Appenzeller, J. Wienands, M. Breitenbach, et al. 2002. Phage display based cloning of proteins interacting with the cytoplasmic tail of membrane immunoglobulins. Dev. Immunol. 9: 127-134.
33. Vangelista, L., E. Soprana, M. Cesco-Gaspere, P. Mandiola, G. Di Lullo, R. N. Fucci, F. Codazzi, A. Palini, G. Paganelli, O. R. Burrone, and A. G. Siccardi. 2005. Membrane IgE binds and activates FcεRI in an antigen-independent manner. J. Immunol. 174: 5602-5611.
34. Koncz, G., C. Bodor, D. Kovesdi, R. Gati, and G. Sarmay. 2002. BCR mediated signal transduction in immature and mature B cells. Immunol. Lett. 82: 41-49.
35. Jacob, A., D. Cooney, M. Pradhan, and K. M. Coggeshall. 2002. Convergence of signaling pathways on the activation of ERK in B cells. J. Biol. Chem. 277: 23420-23426.
36. Chen, C. H., W. J. Wang, J. C. Kuo, H. C. Tsai, J. R. Lin, Z. F. Chang, and R. H. Chen. 2005. Bidirectional signals transduced by DAPK-ERK interaction promote the apoptotic effect of DAPK. EMBO J. 24: 294-304.
37. Lens, S. M., B. F. den Drijver, A. J. Potgens, K. Tesselaar, M. H. van Oers, and R. A. van Lier. 1998. Dissection of pathways leading to antigen receptor-induced and Fas/CD95-induced apoptosis in human B cells. J. Immunol. 160: 6083-6092.
38. Berard, M., P. Mondiere, M. Casamayor-Palleja, A. Hennino, C. Bella, and T. Defrance. 1999. Mitochondria connects the antigen receptor to effector caspases during B cell receptor-induced apoptosis in normal human B cells. J. Immunol. 163: 4655-4662.
39. Herold, M. J., A. W. Kuss, C. Kraus, and I. Berberich. 2002. Mitochondria-dependent caspase-9 activation is necessary for antigen receptor-mediated effector caspase activation and apoptosis in WEHI 231 lymphoma cells. J. Immunol. 168: 3902-3909.
40. Pettersen, R. D., G. Bernard, M. K. Olafsen, M. Pourtein, and S. O. Lie. 2001. CD99 signals caspase-independent T cell death. J. Immunol. 166: 4931-4942.
41. Johansson, U., K. Higginbottom, and M. Londei. 2004. CD47 ligation induces a rapid caspase-independent apoptosis-like cell death in human monocytes and dendritic cells. Scand. J. Immunol. 59: 40-49.
42. 2 signaling correlates with protection from apoptosis in WEHI-231 B cells. Blood 103: 168-176.
43. Mlinaric-Rascan, I., and B. Turk. 2003. B cell receptor-mediated nuclear fragmentation proceeds in WEHI 231 cells in the absence of detectable DEVDase and FRase activity. FEBS Lett. 553: 51-55.
44. Hakem, R., A. Hakem, G. S. Duncan, J. T. Henderson, M. Woo, M. S. Soengas, A. Elia, J. L. de la Pompa, D. Kagi, W. Khoo, et al. 1998. Differential requirement for caspase 9 in apoptotic pathways in vivo. Cell 94: 339-352.
45. Bras, M., B. Queenan, and S. A. Susin. 2005. Programmed cell death via mitochondria: different modes of dying. Biochemistry 70: 231-239.
46. Bouchon, A., P. H. Krammer, and H. Walczak. 2000. Critical role for mitochondria in B cell receptor-mediated apoptosis. Eur. J. Immunol. 30: 69-77.
47. Daugas, E., S. A. Susin, N. Zamzami, K. F. Ferri, T. Irinopoulou, N. Larochette, M. C. Prevost, B. Leber, D. Andrews, J. Penninger, and G. Kroemer. 2000. Mitochondrio-nuclear translocation of AIF in apoptosis and necrosis. FASEB J. 14: 729-739.